natgillin/translations-raw huggingface dataset:
Maintenance therapy every 4 weeks (Q4) at the same cumulative dose as the bi-weekly (Q2) dose has been studied in adult patients with stable residual Gaucher disease type 1. 
U odraslih bolesnika sa stabilnom rezidualnom Gaucherovom bolešću tipa 1 ispitana je terapija održavanja svaka 4 tjedna (Q4) istom kumulativnom dozom kao i kod primjene lijeka svaka 2 tjedna (Q2).
The mixed solution in the vial cannot be stored and should be promptly diluted in an infusion bag; only the diluted solution can be held for up to 24 hours if it is kept cool (2°C - 8°C) and in the dark. 
Samo razrijeđena otopina može se čuvati do 24 sata, i to na hladnom (2°C - 8°C) i tamnom mjestu.
• Guide for Healthcare Professionals Treating Patients with Gaucher Disease. 
• Priručnika za bolesnike s Gaucherovom bolešću koji primaju infuziju kod kuće • Vodiča za zdravstvene radnike koji liječe bolesnike s Gaucherovom bolešću
After reconstitution it is a clear, colourless liquid, free from foreign matter. 
Nakon rekonstitucije, otopina je bistra, bezbojna tekućina i ne sadrži vidljive čestice.
Excipients: For the full list of excipients, see section 6.1. 
Za cjeloviti popis pomoćnih tvari, vidjeti dio 6.1.
The reconstituted solution contains 40 units imiglucerase per ml. 
Rekonstituirana otopina sadrži 40 jedinica imigluceraze po ml.
Use Aseptic Technique 
Primijenite aseptički postupak Rekonstitucija
Do not use this medicine after the expiry date printed on the labelling after the letters “EXP”. 
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na naljepnici iza oznake "Rok valjanosti".
A range of dosage regimens has proven effective towards some or all of the non-neurological manifestations of the disease. 
U liječenju nekih ili svih neneuroloških manifestacija bolesti učinkovitim su se pokazali brojni režimi doziranja.
After reconstitution, the solution contains 0.62 mmol sodium (200 U/5 mL). 
Nakon rekonstitucije, otopina sadrži 0,62 mmol natrija (200 U/5 ml).
Patients should be advised to discontinue infusion of the product and contact their physician if these symptoms occur. 
Bolesnici se moraju savjetovati da u slučaju pojave spomenutih simptoma prekinu infuziju i jave se svom liječniku.
The reconstituted volume is 10.6 ml. 
Volumen rekonstituirane otopine je 10,6 ml. pH vrijednost rekonstituirane otopine iznosi približno 6,1.
After reconstitution, the solution contains 1.24 mmol sodium (400 U/10 mL). 
Nakon rekonstitucije, otopina sadrži 1,24 mmol natrija (400 U/10 ml).
Before further dilution, visually inspect the reconstituted solution in each vial for foreign particles and discoloration. 
Prije daljnjeg razrjeđivanja treba vizualno pregledati je li rekonstituirana otopina u bočici promijenila boju i ima li u njoj vidljivih čestica.
Intravenous use Read the package leaflet before use. 
Prije uporabe pročitajte uputu o lijeku.
Cerezyme 200 Units powder for concentrate for solution for infusion This medicinal product contains sodium and is administered in 0.9% sodium chloride intravenous solution (see section 6.6). 
Cerezyme 200 jedinica prašak za koncentrat za otopinu za infuziju Ovaj lijek sadrži natrij i primjenjuje se u 0,9%-tnoj otopini natrijevog klorida za intravensku primjenu (vidjeti dio 6.6).
Cerezyme 400 Units powder for concentrate for solution for infusion This medicinal product contains sodium and is administered in 0.9% sodium chloride intravenous solution (see section 6.6). 
Cerezyme 400 jedinica prašak za koncentrat za otopinu za infuziju Ovaj lijek sadrži natrij i primjenjuje se u 0,9%-tnoj otopini natrijevog klorida za intravensku primjenu (vidjeti dio 6.6).
Changes from baseline in hemoglobin, platelets, liver and spleen volumes, bone crisis, and bone disease comprised a predefined composite endpoint; achievement or maintenance of established Gaucher disease therapeutic goals for the hematologic and visceral parameters comprised an additional endpoint. 
Promjene u odnosu na početne vrijednosti hemoglobina, trombocita, volumena jetre i slezene, koštane krize te bolesti kostiju činile su unaprijed definiranu kompozitnu mjeru ishoda.
Immune system disorders Hypersensitivity reactions 
Poremećaji imunološkog sustava
One vial contains 200 units of imiglucerase. 
Jedna bočica sadrži 200 jedinica imigluceraze.
This medicine contains sodium and is administered in 0.9% sodium chloride intravenous solution. 
Ovaj lijek sadrži natrij i primjenjuje se u 0,9%-tnoj otopini natrijevog klorida za intravensku primjenu.
Infusion of Cerezyme at home may be considered for patients who are tolerating their infusions well for several months.. Decision to have patient move to home infusion should be made after evaluation and recommendation by the treating physician. 
Odluka da se bolesnik prebaci na primjenu infuzije kod kuće smije se donijeti tek nakon procjene i preporuke liječnika specijalista koji liječi bolest.
The reconstituted volume allows accurate withdrawal of 5.0 ml (equal to 200 units) from each vial. 
Volumen rekonstituirane otopine omogućuje uzimanje točno 5,0 ml (jednako količini od 200 jedinica) otopine iz svake bočice.
Cerezyme 200 Units Powder for concentrate for solution for infusion Cerezyme 400 Units Powder for concentrate for solution for infusion 
Cerezyme 200 jedinica prašak za koncentrat za otopinu za infuziju Cerezyme 400 jedinica prašak za koncentrat za otopinu za infuziju
The reconstituted volume allows accurate withdrawal of 10.0 ml (equal to 400 units) from each vial. 
Volumen rekonstituirane otopine omogućuje uzimanje točno 10,0 ml (jednako količini od 400 jedinica) otopine iz svake bočice.
Mannitol, sodium citrate (to adjust pH), citric acid monohydrate (to adjust pH), polysorbate 80. 
6.1 Popis pomoćnih tvari manitol natrijev citrat (za podešavanje pH) citratna kiselina hidrat (za podešavanje pH) polisorbat 80
- The other ingredients are: mannitol, sodium citrate, citric acid monohydrate and polysorbate 80. 
- Drugi sastojci su: manitol, natrijev citrat, citratna kiselina hidrat, polisorbat 80.
After reconstitution, the solution contains 40 units (approximately 1.0 mg) of imiglucerase per ml (200 U/5 ml). 
Nakon rekonstitucije otopina sadrži 40 jedinica (približno 1,0 mg) imigluceraze po ml (200 U/5 ml).
Withdraw 5.0 ml reconstituted solution from each vial and combine the withdrawn volumes. 
Povucite 5,0 ml rekonstituirane otopine iz svake bočice i pomiješajte ih.
The pH of the reconstituted solution is approximately 6.1. 
Volumen rekonstituirane otopine je 5,3 ml. pH vrijednost rekonstituirane otopine iznosi približno 6,1.
Patients diagnosed with pulmonary hypertension, in particular, should receive adequate doses of Cerezyme to ensure control of underlying Gaucher disease as well as be evaluated for the need of additional pulmonary hypertension specific treatments. 
Cerezyme kako bi se osigurala kontrola osnovne Gaucherove bolesti kao i procijenila potreba za dodatnim specifičnim lijekovima za plućnu hipertenziju.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (1 VIAL, 5 VIALS, 25 VIALS) 
VANJSKO PAKIRANJE (1 BOČICA, 5 BOČICA, 25 BOČICA)
sodium chloride intravenous solution will retain chemical stability if stored up to 24 hours at 2°C and 8°C under protection from light; but microbiological safety will depend on the reconstitution and dilution having been performed aseptically. 
tnoj otopini natrijevog klorida za intravensku primjenu zadržava kemijsku stabilnost ako se čuva do 24 sata pri temperaturi od 2°C do 8°C, zaštićen od svjetlosti.
Contents of the pack and other information . 
Kako se Cerezyme čuva Sadržaj pakiranja i druge informacije
Withdraw 10.0 ml reconstituted solution from each vial and combine the withdrawn volumes. 
Povucite 10,0 ml rekonstituirane otopine iz svake bočice i pomiješajte ih.
Excipients: mannitol, sodium citrate, citric acid monohydrate and polysorbate 80. 
Pomoćne tvari: manitol, natrijev citrat, citratna kiselina hidrat i polisorbat 80.
After reconstitution, the solution contains 40 units (approximately 1.0 mg) of imiglucerase per ml (400 U/10 ml). 
Nakon rekonstitucije otopina sadrži 40 jedinica (približno 1,0 mg) imigluceraze po ml (400 U/10 ml).
Once this dose is found your doctor will still keep a check on your responses to make sure you are using the right dose. 
Vaš odgovor na lijek kako bi bio siguran da uzimate primjerenu dozu.
Infusion site discomfort, infusion site burning, infusion site swelling, injection site sterile abscess, chest discomfort*, fever, rigors, fatigue 
Nelagoda na mjestu primjene infuzije, žarenje na mjestu primjene infuzije, oticanje na mjestu primjene infuzije, sterilni apsces na mjestu injiciranja, nelagoda u prsištu*,
The usual frequency of infusion is once every 2 weeks; this is the frequency of infusion for which the most data are available. 
Za tu učestalost infuzija je dostupno najviše podataka.
Cerezyme 400 Units powder for concentrate for solution for infusion 3 years 
Cerezyme 400 jedinica prašak za koncentrat za otopinu za infuziju 3 godine
One vial contains 400 units of imiglucerase. 
Jedna bočica sadrži 400 jedinica imigluceraze.
After reconstitution, each vial of Cerezyme contains 200 units of imiglucerase in 5.0 ml (40 units per ml). 
Nakon rekonstitucije jedna bočica lijeka Cerezyme sadrži 200 jedinica imigluceraze u 5,0 ml (40 jedinica po ml).
Cerezyme 400 Units powder for concentrate for solution for infusion The reconstituted solution contains 40 units imiglucerase per ml. 
Cerezyme 400 jedinica prašak za koncentrat za otopinu za infuziju Rekonstituirana otopina sadrži 40 jedinica imigluceraze po ml.
Package leaflet: Information for the user Cerezyme 200 Units powder for concentrate for solution for infusion 
Uputa o lijeku: Informacije za korisnika Cerezyme 200 jedinica prašak za koncentrat za otopinu za infuziju imigluceraza
Eighty-nine percent of Q4- and 100% of Q2-treated patients met the therapeutic goals-based endpoint; the difference was not statistically significant based on the 95% CI (-0.231, 0.060). 
Razlika nije bila statistički značajna na temelju 95% CI (-0,231, 0,060).
Cerezyme 200 Units powder for concentrate for solution for infusion Each vial contains 200 units* of imiglucerase**. 
Cerezyme 200 jedinica prašak za koncentrat za otopinu za infuziju Jedna bočica sadrži 200 jedinica* imigluceraze**.
Cerezyme 200 Units powder for concentrate for solution for infusion 2 years 
Cerezyme 200 jedinica prašak za koncentrat za otopinu za infuziju 2 godine
25 vials of powder for concentrate for solution for infusion. 
25 bočica s praškom za koncentrat za otopinu za infuziju.
Cerezyme 200 Units powder for concentrate for solution for infusion The reconstituted solution contains 40 units imiglucerase per ml. 
Cerezyme 200 jedinica prašak za koncentrat za otopinu za infuziju Rekonstituirana otopina sadrži 40 jedinica imigluceraze po ml.
Package leaflet: Information for the user Cerezyme 400 Units powder for concentrate for solution for infusion 
Uputa o lijeku: Informacije za korisnika Cerezyme 400 jedinica prašak za koncentrat za otopinu za infuziju imigluceraza
There is no information on the effect of Cerezyme on brain-based symptoms of patients with chronic neuronopathic Gaucher disease. 
Djelotvornost lijeka Cerezyme na neurološke simptome u bolesnika s kroničnom neuropatskom
After reconstitution, each vial of Cerezyme contains 400 units of imiglucerase in 10.0 ml (40 units per ml). 
Nakon rekonstitucije jedna bočica lijeka Cerezyme sadrži 400 jedinica imigluceraze u 10,0 ml (40 jedinica po ml).
Arthralgia, backache* 
Artralgija, bol u leđima*
• thrombocytopenia 
• trombocitopeniju
Dyspnoea*, coughing* 
Dispneja*, kašalj*
Do not use vials exhibiting foreign particles or discoloration. 
Ne smiju se upotrijebiti bočice koje sadrže vidljive čestice ili u kojima je otopina promijenila boju.
Sixty-three percent of Q4- and 81% of Q2treated patients met the composite endpoint at Month 24; the difference was not statistically significant based on the 95% CI (-0.357, 0.058). 
Razlika nije bila statistički značajna na temelju 95% CI (-0,357, 0,058).
The product diluted in 0.9% sodium chloride intravenous solution will retain chemical stability if stored up to 24 hours at 2°C and 8°C under protection from light; but microbiological safety will depend on the reconstitution and dilution having been performed aseptically. 
Lijek razrijeđen u 0,9%tnoj otopini natrijevog klorida za intravensku primjenu zadržava kemijsku stabilnost ako se čuva do 24
Cerezyme 200 Units Powder for concentrate for solution for infusion imiglucerase 
Cerezyme 200 jedinica prašak za koncentrat za otopinu za infuziju imigluceraza
This medicinal product contains sodium and is administered in 0.9% sodium chloride intravenous solution (see section 6.6). 
Ovaj lijek sadrži natrij i primjenjuje se u otopini natrijevog klorida od 9 mg/ml (0,9%) za intravensku primjenu (vidjeti dio 6.6).
Disease management should be directed by physicians knowledgeable in the treatment of Gaucher disease. 
4.2 Doziranje i način primjene Liječenje bolesti mora voditi liječnik s iskustvom u liječenju Gaucherove bolesti.
It is supplied as a powder which will be mixed with sterile water before it is given. 
Dolazi u obliku praška koji se prije primjene miješa sa sterilnom vodom.
Cerezyme 400 Units Powder for concentrate for solution for infusion imiglucerase 
Cerezyme 400 jedinica prašak za koncentrat za otopinu za infuziju imigluceraza
Anaphylactoid reactions 
Anafilaktoidne reakcije
Cerezyme 200 Units powder for concentrate for solution for infusion To provide sufficient volume to allow accurate dispensing, each vial is formulated to contain an overfill of 0.3 ml. 
Kako bi se osigurao dovoljan volumen lijeka za točno doziranje, svaka bočica sadrži višak od 0,3 ml.
Cerezyme 400 Units powder for concentrate for solution for infusion To provide sufficient volume to allow accurate dispensing, each vial is formulated to contain an overfill of 0.6 ml. 
Kako bi se osigurao dovoljan volumen lijeka za točno doziranje, svaka bočica sadrži višak od 0,6 ml.
After reconstitution, the solution contains 40 units of imiglucerase per ml. 
Nakon pripreme za primjenu otopina sadrži 40 jedinica imigluceraze po mililitru.
Cerezyme 200 Units powder for concentrate for solution for infusion Reconstitute each vial with 5.1 ml water for injections; avoid forceful impact of water for injections on the powder and, by mixing gently, avoid foaming of the solution. 
Cerezyme 200 jedinica prašak za koncentrat za otopinu za infuziju Rekonstituirajte jednu bočicu s 5,1 ml vode za injekcije.
Uncommon ( may affect up to 1 in 100 people): - dizziness - headache - a sensation of tingling, pricking, burning or numbness of the skin - increased heart rate - bluish skin - flushing - fall in blood pressure - vomiting - nausea - abdominal cramping - diarrhoea - pain in the joints - infusion site discomfort - infusion site burning - infusion site swelling - injection site sterile abscess - chest discomfort - fever - rigors - fatigue - backache 
- proljev - bol u zglobovima - nelagoda na mjestu primjene infuzije - žarenje na mjestu primjene infuzije - oticanje na mjestu primjene infuzije - sterilna gnojna upala na mjestu injekcije - nelagoda u prsnom košu
Cerezyme 400 Units powder for concentrate for solution for infusion Reconstitute each vial with 10.2 ml water for injections; avoid forceful impact of water for injections on the powder and, by mixing gently, avoid foaming of the solution. 
Cerezyme 400 jedinica prašak za koncentrat za otopinu za infuziju Rekonstituirajte jednu bočicu s 10,2 ml vode za injekcije.
MARKETING AUTHORIZATION NUMBERS 
PUŠTANJE SERIJE LIJEKA U PROMET
Dilution 
Dojenje
Reconstitute each vial with 10.2 ml water for injections; avoid forceful impact of water for injections on the powder and, by mixing gently, avoid foaming of the solution. 
Izbjegavajte naglo izlijevanje vode za injekcije na prašak, a otopinu miješajte polako da se ne zapjeni.
Eesti sanofi-aventis Estonia OÜ Tel. +372 6 273 488 
Hrvatska sanofi-aventis Croatia d.o.o. Tel: +385 1 600 3 4 00
Common ( may affect up to 1 in 10 people): - breathlessness - coughing - hives/ localised swelling of the skin or lining of the mouth or throat - itching - rash 
- koprivnjača/lokalizirano oticanje kože ili sluznice usta ili grla
EU/1/08/494/005 STELARA 130 mg Concentrate for solution for infusion 
EU/1/08/494/005 STELARA 130 mg Koncentrat za otopinu za infuziju
Content (concentration) 
Sastav (koncentracija) Veličina pakovanja
CAPSULE 
KAPSULE
Pfizer Corporation Austria Gesellschaft M.B.H. 
Pfizer Corporation Austrija Gesellschaft M.B.H.
Teva Pharma Belgium N.V.-S.A 
Teva Pharma Belgija N.V.-S.A
CAPSULE, HARD ORAL USE 
KAPSULE, TVRDE ORALNA PRIMJENA
Fresenius Kabi Hungary Kft. 
Fresenius Kabi Mađarska Kft.
Pfizer Healthcare Ireland 
Pfizer Healthcare Irska
Pfizer Luxembourg Sarl 
Pfizer Luksemburg Sarl
United Kingdom Nrim Limited 
Nrim Limited
Vancomycin Pfizer Healthcare Ireland 
Vancomycin Pfizer Healthcare Irska
INFUSION 
INFUZIJU
POWDER FOR CONCENTRATE FOR 
PRAŠAK ZA KONCENTRAT ZA
United Kingdom Co-Pharma Limited Vancomycin CoPharma 
Co-Pharma Limited Vancomycin CoPharma
Teva Denmark A-S Vancomycin Teva VANCOMYCIN HYDROCHLORIDE 
Teva Danska A-S Vancomycin Teva VANCOMYCIN HYDROCHLORIDE
Mip Pharma Austria Gmbh 
Mip Pharma Austrija Gmbh
Fresenius Kabi Romania S.R.L. 
Fresenius Kabi Rumunjska S.R.L.
Labesfal Laboratorios Almiro, S.A. 
Laboratorios Almiro, S.A.
1.025G VIAL 
1.025G BOČICA
Wockhardt Uk Ltd Vancomycin Wockhardt Uk Ltd 
WockTVRDEt Uk Ltd Vancomycin WockTVRDEt Uk Ltd
CUTANEOUS USE 
CUTANEOUS
VANCOMYCIN 500MG POWDER FOR 
VANCOMYCIN 500MG PRAŠAK ZA
United Kingdom Teva Uk Limited Vancomycin Teva Uk VANCOMYCIN 1000MG VIAL 
Teva Uk Limited Vancomycin Teva Uk VANCOMYCIN 1000MG BOČICA
1000 mg 
and 1000MG
Actavis Group Ptc Vankomicin Actavis VANCOMYCIN 
Actavis Group Ptc Vancomycin Actavis VANCOMYCIN PRAŠAK ZA
POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, POWDER FOR ORAL SOLUTION 
PRAŠAK ZA KONCENTRAT ZA OTOPINU ZA INFUZIJU, POWDER FOR ORAL SOLUTION
United Kingdom Teva Uk Limited Vancomycin Teva Uk VANCOMYCIN 500MG VIAL 
Teva Uk Limited Vancomycin Teva Uk VANCOMYCIN 500MG BOČICA
POWDER FOR SOLUTION FOR INFUSION / POWDER FOR ORAL SOLUTION 
PRAŠAK ZA OTOPINU ZA INFUZIJU / POWDER FOR ORAL SOLUTION
Voxin® 500mg/Vial 
Voxin® 500mg/BOČICA
VANCOMYCIN HYDROCHLORIDE 128.15MG CAPSULE 
VANCOMYCIN HYDROCHLORIDE 128.15MG KAPSULE
Fresenius Kabi France S.A.S. 
Fresenius Kabi Francuska S.A.S.
Vancomicina Kern Pharma 
Kern Pharma, S.L. Vancomicina Kern Pharma
Vancomycin Hospira VANCOMYCIN 1000MG and 500 MG VIAL 
Vancomycin Hospira VANCOMYCIN 1000MG and 500 MG BOČICA
1020MG VIAL 
1020MG BOČICA
United Kingdom Actavis Group Ptc Ehf. 
Češka Republika Actavis Group Ptc Ehf.
Hospira Uk Ltd Vanmicira 
Češka Republika Hospira Uk Ltd Vanmicira
1026MG Vial 
1026MG BOČICA
VANCOMYCIN 250MG CAPSULE 
VANCOMYCIN 250MG KAPSULE
Vancomycin Actavis VANCOMYCIN 125MG CAPSULE 
Vancomycin Actavis VANCOMYCIN 125MG KAPSULE
VANCOMYCIN 125MG CAPSULE 
VANCOMYCIN 125MG KAPSULE
United Kingdom Hikma Farmacêutica (Portugal), S.A. 
Češka Republika Hikma Farmacêutica (Portugal), S.A.
Vancomycin Actavis VANCOMYCIN 250MG CAPSULE 
Vancomycin Actavis VANCOMYCIN 250MG KAPSULE
Vancomycin Xellia VANCOMYCIN 250MG CAPSULE 
Vancomycin Xellia VANCOMYCIN 250MG KAPSULE
Orion Corporation Vancomycin Orion VANCOMYCIN 500MG VIAL 
Orion Corporation Vancomycin Orion VANCOMYCIN 500MG BOČICA
Vancomycin Xellia VANCOMYCIN 125MG CAPSULE 
Vancomycin Xellia VANCOMYCIN 125MG KAPSULE
Orion Corporation Vancomycin Orion VANCOMYCIN 1000MG VIAL 
Orion Corporation Vancomycin Orion VANCOMYCIN 1000MG BOČICA
VANCOMYCIN 1000 mg per vial 
VANCOMYCIN 1000 mg per BOČICA
Vancomicina Axelia Vancomycin hydrochloride 500 vial 
Vancomicina Axelia Vancomycin hydrochloride 500
VANCOMYCIN HYDROCHLORIDE 250MG CAPSULE 
VANCOMYCIN HYDROCHLORIDE 250MG KAPSULE
POWDER FOR ORAL SOLUTION, POWDER FOR SOLUTION FOR INJECTION 
PRAŠAK ZA ORALNU OTOPINU, POWDER FOR SOLUTION FOR INJECTION
Fresenius Kabi Bulgaria Eood ванкомицин каби VANCOMYCIN 1000MG VIAL 
Fresenius Kabi Bugarska Eood ванкомицин каби VANCOMYCIN 1000MG BOČICA
VANCOMYCIN HYDROCHLORIDE 1025MG/1025 MG 
HYDROCHLORIDE 1025MG/1025 MG
VANCOMYCIN HYDROCHLORIDE 256MG CAPSULE 
VANCOMYCIN HYDROCHLORIDE 256MG KAPSULE
Mylan Hospital As Vancomycin Mylan VANCOMYCIN 1000MG VIAL 
Mylan Hospital As Vancomycin Mylan VANCOMYCIN 1000MG BOČICA
Vancomicina Axelia Vancomycin hydrochloride 1000 vial 
Vancomicina Axelia Vancomycin hydrochloride 1000
POWDER FOR 
OTOPINU ZA
Fresenius Kabi Bulgaria Eood ванкомицин каби VANCOMYCIN 500MG VIAL 
Fresenius Kabi Bugarska Eood ванкомицин каби VANCOMYCIN 500MG BOČICA
Mylan Dura Gmbh Vancomycin Mylan VANCOMYCIN 500MG VIAL 
Mylan Dura Gmbh Vancomycin Mylan VANCOMYCIN 500MG BOČICA
Vancomycin Sandoz VANCOMYCIN 1000MG VIAL 
Vancomycin Sandoz VANCOMYCIN 1000MG BOČICA
VANCOMYCIN HYDROCHLORIDE 1000000 I.U. 
VANCOMYCIN HYDROCHLORIDE 1000000 I.U. G
VANCOMYCIN HYDROCHLORIDE 125MG CAPSULE 
VANCOMYCIN HYDROCHLORIDE 125MG KAPSULE
Vancomicina Sala VANCOMYCIN 500MG VIAL 
Vancomicina Sala VANCOMYCIN 500MG BOČICA
Mylan Dura Gmbh Vancomycin Mylan VANCOMYCIN 1000MG VIAL 
Mylan Dura Gmbh Vancomycin Mylan VANCOMYCIN 1000MG BOČICA
Vancomicina Normon VANCOMYCIN 500MG VIAL 
Vancomicina Normon VANCOMYCIN 500MG BOČICA
Vancomycin Xellia VANCOMYCIN 1000MG VIAL 
Vancomycin Xellia VANCOMYCIN 1000MG BOČICA
Mylan Hospital As Vancomycin Mylan VANCOMYCIN 500MG VIAL 
Mylan Hospital As Vancomycin Mylan VANCOMYCIN 500MG PRAŠAK ZA
ORAL USE 
USE
Vancomicina Hospira VANCOMYCIN 500MG VIAL 
Vancomicina Hospira VANCOMYCIN 500MG BOČICA
Vancomycin Vocate VANCOMYCIN 500MG VIAL 
Vancomycin Vocate VANCOMYCIN 500MG BOČICA
Fresenius Kabi ванкомицин каби VANCOMYCIN 500MG POWDER FOR 
Fresenius Kabi Bugarska Eood ванкомицин каби VANCOMYCIN 500MG PRAŠAK ZA KONCENTRAT ZA
VANCOMYCIN HYDROCHLORIDE 1025.14MG VIAL 
VANCOMYCIN HYDROCHLORIDE 1025.14MG BOČICA
Vancomycin Vocate VANCOMYCIN 1000MG VIAL 
Vancomycin Vocate VANCOMYCIN 1000MG BOČICA
United Kingdom Mip Pharma Gmbh Vancomycin Mip Pharma Gmbh 
Mip Pharma Gmbh Vancomycin Mip Pharma Gmbh
Vancomycine Teva VANCOMYCIN 500MG VIAL 
Vancomycine Teva VANCOMYCIN 500MG BOČICA
HYDROCHLORIDE 513MG VIAL 
HYDROCHLORIDE 513MG BOČICA
510MG VIAL 
510MG BOČICA
HYDROCHLORIDE 1025MG VIAL 
HYDROCHLORIDE 1025MG BOČICA
Vancomycin Mip VANCOMYCIN 500MG VIAL 
Vancomycin Mip VANCOMYCIN 500MG BOČICA
Vancomycin Xellia VANCOMYCIN 500MG VIAL 
Vancomycin Xellia VANCOMYCIN 500MG BOČICA
Vancomycin Xellia VANCOMYCIN 250MG CAPSULE, HARD ORAL USE 
Vancomycin Xellia VANCOMYCIN 125MG KAPSULE, TVRDE ORALNA PRIMJENA
Vancomycin Mip VANCOMYCIN 1000MG VIAL 
Vancomycin Mip VANCOMYCIN 1000MG BOČICA
Vancomycine Sandoz VANCOMYCIN HYDROCHLORIDE 1G VIAL 
Vancomycine Sandoz VANCOMYCIN HYDROCHLORIDE 1G BOČICA
Lyomark Pharma Vancomycin Lyomark VANCOMYCIN 
Lyomark Pharma Vancomycin
VANCOMYCIN 500 mg per vial 
VANCOMYCIN 500 mg per BOČICA
Vancomycin Noridem VANCOMYCIN 1000MG VIAL 
Vancomycin Noridem VANCOMYCIN 1000MG BOČICA
Vancomycine Mylan VANCOMYCIN 1000MG VIAL 
Vancomycine Mylan VANCOMYCIN 1000MG BOČICA
VANCOMYCIN HYDROCHLORIDE 500000 I.U. 
VANCOMYCIN HYDROCHLORIDE 500000 I.U. BOČICA
Vancomycin hydrochloride 500 Vial 
Vancomycin hydrochloride 500 BOČICA
Vancomycin Noridem VANCOMYCIN 500MG VIAL 
Vancomycin Noridem VANCOMYCIN 500MG BOČICA
Mip Pharma Gmbh ванкомицин Mip VANCOMYCIN 500MG VIAL 
Mip Pharma Gmbh ванкомицин Mip VANCOMYCIN 500MG BOČICA
Vancomycin Actavis VANCOMYCIN 1000MG VIAL 
Vancomycin Actavis VANCOMYCIN 1000MG BOČICA
VANCOMYCIN 1G VIAL POWDER FOR 
VANCOMYCIN POWDER FOR
Vankomicin Actavis VANCOMYCIN 500MG VIAL 
Vankomicin Actavis VANCOMYCIN 500MG BOČICA
1025.2 - 1040.2MG VIAL 
1025.14MG BOČICA
Vancomycin Actavis VANCOMYCIN 500MG VIAL 
Vancomycin Actavis VANCOMYCIN 500MG BOČICA
Mip Pharma Gmbh Vancomycin Mip VANCOMYCIN 1000MG VIAL 
Mip Pharma Gmbh Vancomycin Mip VANCOMYCIN 1000MG BOČICA
Vancomicina Generis VANCOMYCIN HYDROCHLORIDE 500 mg VIAL 
Vancomicina Generis VANCOMYCIN HYDROCHLORIDE 500 mg BOČICA
Cnp Pharma Gmbh Vancomycin "cnp" VANCOMYCIN 1000MG VIAL 
Cnp Pharma Gmbh Vancomycin "cnp" VANCOMYCIN 1000MG BOČICA
Vancomycin Hikma VANCOMYCIN 500MG VIAL 
Vancomycin Hikma VANCOMYCIN 500MG BOČICA
Mip Pharma Gmbh Vancomycin Mip VANCOMYCIN 500MG VIAL 
Mip Pharma Gmbh Vancomycin Mip VANCOMYCIN 500MG BOČICA